Why you shouldn’t be happy with $137 insulin

Eli Lilly and Co. recently announced with some fanfare that it was manufacturing a generic version of its own best-selling insulin brand, Humalog, which it would sell for half off — $137.35 versus about $275. David Ricks, the chief executive of Lilly, said the company was making this seemingly beneficent gesture because “many patients are […]

Find jobs at Careers by KevinMD.comSearch thousands of physician, PA, NP, and CRNA jobs now. Learn more.


Read the full post on KevinMD.com